Germany To Tackle Cell And Gene Therapy Funding Barriers
If approved, new legislation would allow hospitals to apply for funding for ATMPs before marketing authorization.
You may also be interested in...
Lawyer and industry expert Alexander Natz sets out some important dos and don’ts for securing a successful launch of an advanced therapy in Germany.
The Netherlands calls for multi-country price negotiations for gene therapy Zynteglo.
The Valletta Group says that cancer drugs, treatments for autoimmune diseases, orphan medicines and biosimilars are among the products it is targeting in its joint procurement efforts.